CHPA Quantifies OTCs’ Overall Value To Promote Expanded Access
This article was originally published in The Tan Sheet
Executive Summary
Information from the CHPA-commissioned study could help improve policymakers’ understanding of the costs of making OTCs less available as well as the benefits of more Rx-to-OTC switches.